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Statement of the problem 
The primary goal of this project 1s to determine the formal potentials of 
hemoglobin and two cross-linked hemoglobins. The formal potential will be determined 
by the use of spectroelectrochemical technique. This technique is beneficial for 
biochemical research because it employs a small amount of solution for obtaining both 
spectroscopic and electrochemical parameters and properties of redox processes. 
Determination of the formal potential of hemoglobin and cross-linked hemoglobin 
could give an insight into the electron transfer reactions of hemoglobin and cross-linked 
hemoglobin and how cross-linking affects the accessibility of the heme groups and its 
formal potential. 
The goal of chemical modification and cross-linking of all free hemoglobin is to 
decrease the oxygen affinity of the free hemoglobin, to prevent its dissociation into a.{3 
dimers, to achieve a molecular engineering which would produce an active stabilized 
protein, and to develop a suitable hemoglobin derivative capable of clinical use as a 
blood substitute. Spectroelectrochemical technique could be used for 
qualitative/quantitative analysis of hemoglobin and cross-linked hemoglobin. 
2 
Hemoglobin Background 
Hemoglobin, a tetramer with four heme moieties (Fig .1), functions as the oxygen 
carrying protein in erythrocytes (red blood cells). Hemoglobin binds molecular oxygen 
to its heme irons at the lungs and delivers it to the various tissues throughout the body. 
It also transports carbon dioxide, a by-product of oxidation from the tissues back to the 
lungs to be exhaled. 1-4 
The human hemoglobin molecule has four chains: two identical a chains, each 
with 141 amino acids residues with molecular weight of 15, 126 daltons, and two identical 
(3 chains, each with 146 amino acid residues with molecular weight of 15,867 daltons. 
Each heme group has a molecular weight of 616 daltons. Thus, a molecule of human 
hemoglobin tetramer has a molecular weight of 64,450 daltons. 1 In humans, several 
hemoglobins occur normally: A0 (main component of human red cells), F (fetal 
hemoglobin), and A2 (minor component of human red cells). They all contain four 
subunits but differ in their primary structure (amino acid sequence) of the globin. 2-5 
The hemoglobin molecule has a twofold axis of symmetry. Each dimer contains 
one a and (3 chain, which are held tightly together by atomic interactions. Buried in the 
midst of the globin a and (3 chains are the four heme groups containing ferrous ion, 
protected from oxidation by a hydrophobic environment. 5 The iron atom in the heme 
group can be in the ferrous ( +2) or the ferric ( +3) oxidation state, and the 
corresponding forms of hemoglobin are called ferrohemoglobin and ferrihemoglobin ( also 
known as methemoglobin). Methemoglobin, containing the + 3 oxidation state of iron, 
cannot bind oxygen. Only ferrohemoglobin can bind oxygen. 6 
3 
Figure 1. Structure of Heme group 

5 
Hemoglobin (ferro) exists in two forms: deoxyhemoglobin (without oxygen), and 
oxyhemoglobin ( with oxygen). Deoxyhemoglobin assumes the tense (T) conformation and 
oxyhemoglobin assumes the relaxed (R) conformation. The T state is physically more 
constrained than the R state. The stability of the T state decreases with successive 
oxygenation of the heme group, and as a result the molecules undergo a transition to the 
R state with the release of the constraints and an increase in oxygen affinity .5 The 
principal physiologic effectors (regulators) of the binding of oxygen by hemoglobin 
within the red cells are H+, 2,3-bisphosphoglycerate (2,3-BPG), and CO2 • Other 
regulators, such as c1- and adenosine triphosphate (ATP), also decrease oxygen affinity, 
but their physiological roles are minor. 5 These regulators affect the oxygen binding 
properties of hemoglobin by binding to sites on the protein far from where oxygen is 
bound. 5•6 The hemoglobin molecule acts in a cooperative manner in binding and 
releasing molecular oxygen. The binding of an oxygen molecule to any of the heme 
groups of hemoglobin is affected by the state of the other three heme groups. The first 
oxygen binds weakly to heme, the second and the third oxygens bind more strongly, and 
the last oxygen binds with two or three orders of magnitude greater than the first 
oxygen. 1 
Hemoglobin in solution has the ability to bind oxygen. In theory, it could be used 
in place of red blood cells.5 Hemoglobin as a blood substitute has the following 
advantages over whole blood: it does not carry viral infections, it has a longer shelf-life, 
and there is no need for blood type matching.5 However, free hemoglobin in solution has 
a higher oxygen affinity because outside the red cell the normal allosteric effector, 2,3-
6 
BPG, is absent. Free hemoglobin dissociates into half-molecules (a/3 dimers) that are 
rapidly removed from the circulation by the kidney after filtration in the glomerulus. 
Once filtered, a high concentration of protein in the renal tubules can cause tubular 
obstruction and consequent renal failure. 5 Hence, modification of hemoglobin is 
necessary for improving these disadvantages inherent in cell-free hemoglobin.5 
Cross-linking of Hemoglobin 
Various chemical reagents have been used for the chemical modification and 
cross-linking of hemoglobin. These reagents are: acetaldehyde, mono-(3,5-
dibromosalicy l)fumarate, 2-nor-2-formy lpyridoxal 5 '-phosphate (NFPLP), bis-(3, 5-
dibromosalicy l)fumarate, etc. 5 
All these reagents cross-link hemoglobin intermolecularly or intramolecularly at 
different sites and involve different amino residues of the globin. 5 When hemoglobin is 
chemically modified, the T to R transition is altered; this alteration manifests itself in 
a reduced Bohr effect (effect of H+). 
Bis-(3,5-dibromosalicyl) fumarate (DBSF) can be used to cross-link hemoglobin. 
The product of the cross-linking depends upon the type of hemoglobin used. {3{3 
hemoglobin results from using oxyhemoglobin and aa hemoglobin results from using 
deoxyhemoglobin. DBSF reacts selectively with oxyhemoglobin to cross-link the {3 chains 




DBSF also reacts selectively with deoxyhemoglobin to cross-link the a chains. The cross-
linking lies between lysine-99a1 and lysine-99a2 spanning the central cavity of the 
tetramer. Lysine-99a1 and lysine-99a2 are located within a cluster of charged amino acid 
7 
residues very near the middle of the hemoglobin molecules. 7 It has been found that 
DBSF cross-linked hemoglobin has increased thermal stability. 5 Electrochemical and 
spectroelectrochemical studies of lysine (99)ai-lysine(99)a2 and lysine (82)/11-lysine 
(82)(32 and cross-linked hemoglobin will be made in this Project. 
Hemoglobin Electrochemistry 
Hemoglobin possesses functional groups (heme groups and amino residues) that 
can be readily oxidized or reduced by chemical redox agents. But, it is difficult for 
hemoglobin to undergo facile oxidation or reduction at electrodes. The reasons for this 
behavior are ascribed to hemoglobin's extended three-dimensional structure which results 
in inaccessibility of the electroactive center, and its adsorption onto and subsequent 
passivation of the electrode surface. 10-17 Hemoglobin exhibits a very slow rate of electron 
transfer so that no useful currents are observed at conventional electrodes, even with the 
application of relatively large overpotentials. 18 
An approach that has been successfully applied to obtain electrochemical 
information concerning hemoglobin involve the use of low molecular weight "mediator 
titrant". These mediator titrant compounds (methylene blue, 19 thioneine, 20 toluidine blue, 21 
and janus green, 22 brilliant cresyl blue23 , and bromopyrogal red24) are either added to the 
solution of hemoglobin or the working electrode is chemically modified with one or two 
of these compounds. When these mediator compounds are added to hemoglobin in low 
concentration, they serve as electron transfer intermediaries by carrying out the chemical 
oxidation or reduction of hemoglobin away from the electrode surface. The mediator 
8 
compound is electrolyzed at its characteristic redox potential and in a succeeding 
chemical step effects the desired redox conversion of hemoglobin. 21 •25 
The results obtained from using chemically modified electrodes (CME) show that 
hemoglobin undergoes a quasi-reversible electrochemical response to an applied potential 
with reaction rates of the oxidation being much slower than the reduction. 19-24 The only 
exception is at a Janus Green modified platinum electrode, which shows the opposite 
behavior. 22 The electrochemical behavior of hemoglobin is strongly dependent upon pH, 
electrolyte, and other solution conditions. 18 
Hiroyuki Ohno et al. applied solid state electrochemistry to study hemoglobin by 
casting polyethylene oxide (PEO)-modified hemoglobin onto an indium tin oxide (ITO) 
electrode. 26 They found out that PEO-hemoglobin was electrochemically reduced and 
oxidized reversibly in PEO oligomers or poly (oligo-(oxyethylene) methacrylate) 
containing KCI. Higher supporting electrolyte concentration and more negative potential 
were effective for faster redox reactions. 26-30 
TECHNIQUES 
Various electrochemical methods had been used m the literature to study 
hemoglobin. These methods include cyclic voltammetry (CV), single potential 
chronoabsorptometry (SPA/CA), derivative cyclic voltabsorptometry (DCVA), double 
potential step chronoabsorptometry, polarography, and spectroelectrochemical methods. 
In all these methods, the working electrode is either modified with mediator/promoter 
compounds or is unmodified. Some methods have mediator compounds added to the 
9 
solution to facilitate electron transfer. 
Cyclic Voltammetry 
Cyclic voltammetry (CV) is a technique for measuring the formal potential of a 
half-reaction when both reduced and oxidized forms are stable enough for a 
voltammogram (current-potential curve) to be obtained. 31 It measures the current that 
flows at an electrode as a function of the potential applied to the electrode. 32 
In CV, the potential of a stationary working electrode is changed linearly with 
time starting from a potential where no electrode reaction occurs and moving to a 
potential where reduction or oxidation of the substrate occurs. For an oxidized substrate, 
the potential starts from a value more positive to its formal potential and is then scanned 
in the negative direction. As the potential approaches the formal potential, a faradaic 
current is observed, which is due to the reduction of the substrate at the electrode 
surface. Eventually, the electrode surface region is depleted in oxidized compounds and 
a diffusion layer forms, causing the current to tail off, forming a peak shape. The 
direction of the potential scan can be reversed and scanned positive. Upon scanning 
positive, faradaic current of opposite sign appears as the substrate is regenerated through 
an oxidation reaction. The time scale of the experiment is controlled by the scan ( or 
sweep) rate. A supporting electrolyte is present to repress migration of charged reactants 
and products. The CV has several distinguishing characteristics (Fig. 2): the cathodic 
(Epc) and anodic (ErJ peak potentials, the cathodic (ire) and anodic (ipa) peak currents, and 
the half-wave potential (E112). 
31 For a simple reversible, redox reaction, the potential of 
10 
Figure 2. Example of a typical cyclic voltammogram of 6 mM K3FE(CN)6 in 1.0 M 
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the reduction Ere differs from the potential of the oxidation peak Era in the reverse scan 
by 59/n mV. 32 The formal potential, E0 lies midway between Epcand Era· 
The peak current for a reversible system is described by the Randles-Sevcik 
equation. 
ip = 2.69 X 105 n312 A D112 v112 c· (1) 
Where ir = peak current 
A = area of the electrode in cm2 
n = number of electrons transferred 
D = diffusion coefficient in cm2 / s 
C* = concentration in mol/cm3 
v = scan rate, V /s 
SPECTROELECTROCHEMISTRY 
Spectroelectrochemistry is the combination of two quite different techniques, 
spectroscopy and electrochemistry. It is used to study the redox chemistry of inorganic, 
organic, and biological molecules. Oxidation states are changed electrochemically by 
addition or removal of electrons at an electrode while spectral measurements are made 
simultaneously on the solution adjacent to the electrode. 33-38 The most frequently used 
optical technique in spectroelectrochemistry is absorption spectroscopy in the ultraviolet, 
visible or infrared region. 
The most important instrumental part of thin-layer spectroelectrochemical 
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technique is the thin-layer cell. The most commonly used cell is the optically transparent 
thin-layer electrochemical cell (OTTLE). 33 The working electrode could be an optically 
transparent electrode (OTE). OTE can consist of a very thin transparent conductive film 
of metal or metal oxide such as indium oxide deposited on a transparent substrate (glass 
or quartz), a gold minigrid, a platinum minigrid, or platinum gauze. In OTTLE, the 
optical beam axis is perpendicular to the electrode surface. Another type of thin-layer 
spectroelectrochemical cell being used is the long optical path thin-layer electrochemical 
cell (LOPTLC). It has the similar working electrode as OTTLE but, its optical beam 
axis is parallel to the electrode surface. 33 
In an ideal thin-layer cell, the peak potentials ( cathodic and anodic), for cyclic 
voltammogram (CV), current-potential (i-E) curves should coincide with zero peak 
separation and both peak potentials should correspond to the formal redox potential 
E0 • 34·39 The integrated charges under each of the i-E curves for the anodic and cathodic 
scans, Qa and Qc, should be equal. Equal values of Qa and Qc indicate retention of the 
solution species within the electrolysis volume and it also assumes that the 
concentrations of the oxidized and reduced species are uniform throughout the thin-layer 
cell cavity. 34•39 
To approach these conditions experimentally, the thickness of the cell cavity has 
to be as small as possible in order to minimize concentration gradients. The sweep rate 
should be as small as possible also. However, the smaller the thickness of the cell cavity, 
the larger the potential gradient buildup across the surface of the working electrode. 40 
For a reversible reaction in a thin-layer cell, the peak current occurs when E = 
E°' and is given by equation 2. 40 
i = n2F 2vVC * P =-=------'-~o- (2) 
4RT 
where C0 • = bulk solution concentration in mol. cm-3 
V = cell volume in liter 
v = scan rate in mV/s 
T = temperature in Kelvin 
F = Faraday's constant in coulombs 
n = no of electrons transferred 
R = gas constant in J K 1 moi-1 
iP = peak current in Amperes 
A typical scan voltammogram in a thin layer cell is shown in Figure 3. 
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Thin-layer spectroelectrochemistry can be used to obtain spectra information at 
fixed wavelength(s) (usually peak absorbance for the sample), formal reduction potentials 
(E0 '), and electron transfer number (n) of redox couples. The redox couple is converted 
incrementally from one oxidation state to another by a series of applied potentials. At 
each applied potential, the absorbance is monitored as a function of time. After steady 
state absorbance is obtained, the potential is then stepped to another potential and the 
corresponding absorbance values of oxidized/reduced species are determined 
spectroscopically. 
The redox potential of a thin layer solution is adjusted precisely by the applied 
potential as determined for the reversible system, 
15 
Figure 3. Shows a theoretical cyclic current-potential curve for a reversible reaction in 
a thin layer cell using equation 2. (adapted from Bard and Faulkner.40) 
16 
0.. 
0 + e ~ R (3) by the N ernst Equation 
E = E 0 ' + 0.059 log IQl (4) 
n [R] 
Where n = number of electrons transferred 
[ 0 ] oxidized species 
[ R ] = reduced species 
E = applied potential 
E0 ' = formal reduction potential 
17 
Although the applied potential, E, controls the ratio [0]/[R] at the electrode 
surface, the ratio in the thin solution layer quickly adjusts to the same ratio by 
electrolysis. 42-44 
Based on the Nernst Equation, a Nerstian plot of applied potential vs log [O]/[R] 
is a straight line with a slope of 0.059/n and an intercept equal to E0 ' value. The ratio 
of [O]/[R] can be calculated from the values obtained from the maximum absorbance 
peaks and is given by the equation: 
log IQl = 
[R] 
Where A1 = absorbance of the reduced form 
A2 = steady-state absorbance at any applied potential 






An EG &G Princeton Applied Research Company Potentiostat/Galvanostat model 
273 with a RE0091 X-Y recorder or Versastat potentiostat with an IBM HP 7371 plotter 
was used to obtain potential readings. Potentials were measured against a Saturated 
Calomel Electrode (SCE), (Fisher Scientific Company). The Ultra-Violet/Visible 
experiments were performed on a Hewlett Packard 8452A diode Array 
Spectrophotometer (equipped with an Epson FX-80 printer, and a Gateway 2000 
480DX2/50 PC computer with Hewlett Packard HP89531A operating software). The 
temperature of the sample in the semi-microcell inside the spectrophotometer cell holder 
was controlled by VWR Scientific model 1167 Digital programmable temperature 
controller. Reagent weighings were performed on a Sartorius analytical balance. pH 
measurements were made on Jenco 672 digital pH/MV /Temp meter. Sonication of the 
working electrode was performed on Branson 1200 Ultrasonic cleaners. Polishing of the 
electrodes were done on a Buchler Ecomet III polisher. Four-neck electrochemical cells 
were used for the cyclic voltammetry experiments. 
18 
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Chemicals and Samples 
Sodium ferricyanide and potassium ferricyanide (City Chemical Corporation), 
potassium chloride and sodium chloride (Aldrich), anhydrous sodium phosphate (E-K 
Industries), monobasic dihydrate sodium phosphate and sodium hydroxide (Fisher 
Scientific Company) were used as received. 
Hemoglobin, lysine (99)aclysine (99)a2 cross-linked hemoglobin, and lysine 
(82)/3 1-lysine (82)/32 cross-linked hemoglobin were obtained from Dr. K. Olsen's 
Laboratory. Samples were refrigerated at 4°C at all times except during experimentation. 
Spectroelectrochemical Analysis 
Instrumental set-up 
A 4mm optical pathlength semi-micro fluorescence cell (Hellman cell Inc.) 
served as both the electrochemical and spectroscopic cell. Indium oxide coated glass was 
used as a spacer (3 .19mm thick) inside the cell to make the cell a thin-layer cell. The 
electrochemical component of the system are made up of a potentiostat, a recorder, and 
three electrodes. A Platinum gauze, Platinum wire, (D. F. Goldsmith Chemical & Metal 
Corporation Evanston IL), Saturated Calomel Electrode (SCE) were used as the working, 
counter, and reference electrodes, respectively. The semi-microcell was placed in the 
optical path of the Hewlett Packard 8452A diode array spectrophotometer in such a way 
that the optical beam axis is perpendicular to the electrode surface/solution. 
The incoming optical light passes through the cell cavity, which is defined by the 
polished optically transparent walls of the cell, the working electrode, counter electrode, 
20 
spacer, and the solution layer thickness estimated to be 0.81mm (0.295mm is the 
electrolyzed layer and 0.515mm houses the counterelectrode and the salt bridge for the 
reference electrode). 
Figure 4 shows the schematic diagram of the instrumental setup. 
Preparation of samples 
Hemoglobin and cross-linked hemoglobins eluted from DEAE-sephadex A-50 with 
pH 8.5 tris-buffer were dialyzed in the refrigerator for 24 hours in a dialysis bag with 
phosphate buffer. After dialysis, the hemoglobin and its cross-linked products were ready 
for spectroelectrochemical studies. They were refrigerated at 4°C when not in use. The 
O. lM phosphate buffer system consisted of sodium phosphate, monobasic dihydrate 
sodium phosphate, sodium hydroxide, which was usually added to adjust the pH of the 
system to the desired pH of 7. 0, and O. 1 potassium chloride. The phosphate buff er 
served as the electrolyte and the solvent for the spectroelectrochemical studies. 
During experimentation, the temperature of hemoglobin and its cross-linked 
products were kept at 25°C with the aid of a VWR Digital Programmable temperature 
controller. 
Experimental Procedure 
The platinum (Pt) gauze, the Pt wire, and the spacer were washed and sonicated 
in between sets of experimental determinations to ensure that any adsorbed 
molecules/particles were desorbed and rinsed away. This procedure ensured a clean, 
21 
Figure 4. Schematic diagram of the spectroelectrochemical setup: (a) Platinum gauze; 










fresh, and approximately constant electrode surface area. A salt bridge was made by 
heat swelling of Agar gel and KCl in water. The resulting gel was then placed inside a 
small diameter rubber tubing while hot and allowed to solidify. When not in use, the salt 
bridge was stored in a solution of KCI. The salt bridge was connected to the narrow end 
of a glass pipette, the upper part of which was connected to a small plastic container 
with a hole drilled at the bottom of it. This home-made salt bridge system housed the 
SCE electrode, and it also served as the connector of the solution under investigation and 
the referenced solution (the same in all respect as the sample solution). 
The cleaned electrodes, the rubber tube part of the salt bridge system, and the 
spacer were placed in a semi-microcell, which in turn, was placed inside the 
spectrophotometer cellholder. Once in place, the cell was filled to the top with the 
sample via a 5ml syringe. The Pt Gauze working electrode, the Platinum wire 
counterelectrode, and the reference electrode were then connected to the potentiostat. 
At the start of each set of experiments, the absorbance of the semi-mirocell with 
its contents, and the phosphate buffer was scan as a blank. Running of the blank was 
done every two hours to ensure the stability of the UV-VS Spectrophotometer. The 
spectrum was taken while the spectrophotometer was in the absorbance-wavelength mode 
with the potentiostat on and with a specified applied potential. Subsequent spectra were 
taken when a fairly constant absorbance was obtained for the applied potential. This 
usually was 120 seconds for the K3Fe(CN)6 system. The potential was then stepped up 
to another value and the spectrum taken when a constant absorbance value was obtained. 
Before each potential step, the system was kept at a more positive potential (for example, 
24 
at 0.50V for K3Fe(CN)6), to allow the thin-layer solution to contain only the oxidized 
form. The spectrum was printed after every determination. 
Electrochemical Experimental Setup 
For each experiment, the solution was purged with N2 gas before use. Potentiostat 
parameters were set as follows: scan rate 4mV/s, unless otherwise specified, low pass 
filters, reference 0.24150 SCE, potential windows of +0.50V to -0.20V for Fe(CN)/ 
experiments. The Fe(CN)/ solution inside the four-necked electrochemical cell was 
purged for 10 minutes and a blanket of N2 gas was maintained over the surface of the 
solution to avoid oxygen interference and gas stream disturbance during the entire 
experimental period. The three electrodes (Pt wires, SCE, as auxiliary, working, 
reference electrodes respectively) were inserted into the solution and connected to their 
corresponding cables on the Versastat potentiostat/Par 273 Potentiostat. All the necessary 
switches were turned on and the experiment was started at this point. Model 250 
electrochemical analysis software does all the current versus potential output adjustments 
automatically for the Versastat potentiostat. 
Concentration Determination 
The concentration of hemoglobin and cross-linked hemoglobin were determined 
using the spectrophotometer. The absorbance peak at 542nm was used to calculate the 
concentration of oxyhemoglobin when the solution is essentially oxyhemoglobin. The 
absorbance peak at 406nm was used to calculate the concentration of methemoglobin 
25 
when the solution is essentially methemoglobin using the Beer-Lambert equation. 
A= e b c (3) 
Where A = absorbance at 542nm 
e = molar absorptivity in L mo1- 1 cm-1 
b = optical pathlength in cm 
c = concentration in moles/liter 
Figures 5, 6 and 7 show the spectra of hemoglobin, aa hemoglobin, and pp 
hemoglobin respectively. From the spectra it appears that there are no significant 
differences between their spectra. 
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Figure 5. Spectrum of 4.429 micromolar hemoglobin in pH 7.0, 0.10M phosphate + 
0.1 OM KCI buffer system. 
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Figure 6. Spectrum of 2.017 micromolar aa hemoglobin in pH 7.0, 0.10M phosphate 
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Figure 7. Spectrum of 6.297 micromolar 00 hemoglobin in pH 7.0, 0.10M phosphate 
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RESULTS AND DISCUSSION 
A spectroelectrochemical system has been designed to study the electrochemical 
behavior of hemoglobin and cross-linked hemoglobin. K3Fe(CN)6, a well studied 
compound, was used as a test system to study the electrochemical and 
spectroelectrochemical behavior of the cell before its application to hemoglobin and 
cross-linked hemoglobin. 
Figure 8 shows the CV current-potential curve obtained for a solution of 5.0mM 
K3Fe(CN)6 in I.OM KCl at a conventional electrochemical cell with Pt wire as the 
working electrode. The electron-transfer process of Fe(CN)/ is quasi-reversible. This 
phenomenon is characterised by an increase in the difference between the oxidation and 
reduction peaks as scan rate increases. 31 · 40 The heterogenous electron-transfer kinetics of 
Fe3+ /Fe2+ redox system depend on the electrode material, pretreatment of the electrode 
surface, and solution condition. 33 
Figure 9 shows the CV obtained for 5.0mM K3Fe(CN)6 in I.OM KCl in the 
homemade spectroelectrochemical cell ( OTTLE). The cathodic and anodic peak currents 
have equal values (0.60mA) with opposite signs. The charges under the integrated area 
are approximately equal. A half-wave potential of 0.208V Vs SCE obtained from the 
32 
33 
Figure 8. Cyclic voltammogram current-potential curve of 5.0mM K3Fe(CN)6 in 1.0M 
KCl at a conventional electrochemical cell. Scan rate of 4 mV/s. 
34 
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Figure 9. Cyclic voltammogram current-potential curve of 5.0mM K3Fe(CN)6 in I.OM 
KCI in the house made spectroelectrochemical cell (OTTLE). Scan rate of lmV/s. 
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midpiont of the difference between the cathodic peak and the anodic peak currents is in 
close agreement with the value reported in the literature. 33 The cyclic voltammetric 
obtained shows a large peak separation. This behavior might be due to non-uniform 
concentration of the oxidized and reduced species throughout the thin-layer cell cavity 
(a common problem with thin layer cells). The effect of which might result in bounded 
diffusion in the cell, uncompensated iR drop, and potential gradient buildup across the 
surface of the working electrode. 39• 40 
Spectroelectrochemistry of ferricyanide 
The wavelength of the maximum absorbance for 5. OmM K3Fe(CN)6 in 1. OM KCl 
is 420nm (Fig. 10) and is chosen as the characteristic wavelength at which to monitor 
reduction. 
Figure 11 shows the plot of absorbance against wavelength for 5. OmM K3Fe(CN)6 
m 1. OM KCl using the spectroelectrochemical cell during a sequence of applied 
potentials. For applied potential of O.289V to O.239V, the absorbance peaks were 
relatively constant (peak (a)). As more negative potential was applied , the peaks height 
decrease reaching the lowest value at applied potential of -O.109V. Assuming that 
Nernstian equilibrium is attained within the cell cavity, the absorbance values measured 
at various applied potentials can be used for the determination of E0 ' and n for the redox 
couple using equation 4 (page 17). The ratio of [Fe(CN)/V[Fe(CN)6
4
-] is controlled by 
the value of EappI.. 
Figure 12 shows the plot of absorbance against potential for 5.OmM K3Fe(CN)6 
38 
Figure 10. Absorption spectrum of 5.0mM K3Fe(CN)6 in 1.0M KCl with the maximum 
absorbance at 420nm. 
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Figure 11. Absorption spectrum of 5.0mM K3Fe(CN)6 in 1.0M KCl at several applied 
potentials: (a) 0.289V, (b) 0.239V, (c) 0.219V, (d) 0.179V, (e) 0.159V, 
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in l.0M KCl at 420nm wavelength. The absorbance values for the cathodic potential 
sweeps remain relatively constant at EappI. values from an initial potential of 0.491 V to 
0.391 V, since the ratio of [Fe(CN)/]/[Fe(CN)/] is essentially zero. As E0 • is 
approached, the absorbance decreases due to the reduction of Fe(CN)l to Fe(CN)/-. 
The absorbance value falls to a very low constant value when the reduction of Fe(CN)l 
to Fe(CN)6
4
- has been completed within the electrolysis volume. 
Figure 13 shows the Nernstian plot for the reduction of Fe(CN)/ to Fe(CN)/. 
The intercept of the plot on the y-axis is equal to the E0 ' value and the slope gives the 
number of electrons transferred. The E0 ' value from the intercept is 0.197V. This value 
compares favorably with the value of 0.208V obtained from the thin-layer cyclic 
voltammogram (Fig. 9). The expected slope from the Nernstian equation should be 
0.059, but the value obtained from the plot is 0.0774. This slope gave an value of 0. 762 
instead of the expected value of 1. 
Fig. 14 shows the plot of absorbance against time for the reduction of Fe(CN)l 
to Fe(CN)6
4
- from potential step of 0.509V to -0.200V at wavelength of 420nm. The 
reduction is essentially 94% complete in 150 seconds. 
Fig. 15 Shows the plot of absorbance against time for the oxidation of Fe(CN)/ 
to Fe(CN)t from potential step of -0.200V to 0.509V at wavelength of 420nm. 
Oxidation is 92 % complete after 180 seconds. 
Fig. 16 shows the voltabsorptometric plot for the reduction of Fe(CN)/ to Fe(CN)6
4
-
from 0.509V to -0.200V, scan rate of lmV/s monitored at 420nm wavelength. 
Since the time of electrolysis can be obtained from (Figs. 14-16), we can calculate 
43 
Figure 12. Plot of absorbance against potential at 420nm wavelength for 5.0mM 
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Figure 13. Nernstian plot for the reduction of 5.0mM K3Fe(CN)6 in 1.0M KCl 
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Figure 14. Plot of absorbance against time for the reduction of Fe(CN)t to Fe(CN)6
4-
from potential step of 0.509V to -0.200V at wavelength of 420nm. 
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Figure 15. Plot of absorbance against time for the oxidation of Fe(CN)64- to Fe(CN)l 







Figure 16. Voltabsorptometric plot for the reduction of Fe(CN)l to Fe(CN)t from 
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53 
the thickness of the thin layer cell. 
The calculated value is 0.355mm. When this value is compared with the estimated value 
of 0.295mm obtained from the cell dimension, one can assume that there is bounded 
diffusion in the cell during electrolysis. 
Figures 9 through 16 show that spectroelectrochemical experiments can be carried 
out using the newly constructed spectroelectrochemical cell. The results obtained show 
that ferricyanide can be reversibly reduced and oxidized using the system. The E0 ' value 
obtained compares favorably with the literature value. 
Cyclic Voltammetry of Hemoglobin 
Figures 17, 18 and 19 show the cyclic voltammograms of hemoglobin, aa 
hemoglobin, and {3(3 hemoglobin respectively. From the cyclic voltammograms, no 
useful currents were observed. These observations confirm the literature's ascertion that 
hemoglobin exhibits such slow rates of electron transfer that no useful currents are 
observed at conventional electrodes, even with the application of relatively large 
overpotentials. 10, 18-24 Hence, it can be deduced that aa, and {3(3 cross-linked hemoglobin 
behave like uncrosslinked hemoglobin in this respect. It also shows that cross-linking 
does not improve or enhance hemoglobin's electrochemical behavior towards 
conventional electrodes. 
Figures 20, 21 and 22 show the plot of absorbance against time for the reduction 
of hemoglobin, aa and {3(3 cross-linked hemoglobin respectively. For the reduction 
process the potential was stepped from 0.589 V to -0.509 V. It is interesting to note 
54 
Figure 17. Cyclic voltarnmogram of 45.7 micromolar hemoglobin in pH 7.0, 0.10M 
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Figure 18. Cyclic voltammogram of 45.7 micromolar aa hemoglobin in pH 7.0, 0. lOM 
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Figure 19. Cyclic voltammogram of 45. 7 micromolar /3/3 hemoglobin in pH 7.0, 0.10M 
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Figure 20. Plot of absorbance against time for the reduction of 4.57 micromolar 
hemoglobin in pH 7.0, 0. IOM phosphate + 0. IOM KCl buffer system from 0.589V to -
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Figure 21. Plot of absorbance against time for the reduction of 5.35 micromolar aa 
hemoglobin in pH 7 .0, 0. lOM phosphate + 0. lOM KCl buffer system from 0.489V to -
0.509V at 406 nm wavelength. 
0.133G:J7 







... __ .---~, 
\_ .. •--........ , 
''-•"\. 
··--. --
o.11sc,o -r-....,....--.-....... -....--,---,---.---.----.-....--,--------,--..,........,....--.-....... -.---,-----




Figure 22. Plot of absorbance against time for the reduction of 5. 35 micromolar (3(3 
hemoglobin in pH 7 .0, 0.10M phosphate + 0.10M KCl buffer system from 0.489V to -
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that, the average reduction time for hemoglobin and its cross-linked products are 
different .. Hemoglobin is 92 % reduced in 200 seconds, aa hemoglobin is 92 % reduced 
in 250 seconds, and {3{3 hemoglobin is 95 % reduced in 130 seconds. Continuing the 
reduction process longer than neccessary leads to a fluctuating absorbance value. The 
reason(s) for this behavior might be due to edge diffusion of the solution at the top of the 
cell that was used to complete the electrolysis circuit, further reduction of the heme 
group adsorption or desorption from the electrode surface, and also the effect of oxygen 
since the spectroelectrochemical cell system is not anaerobic. 
Figures 23 and 24 show the plot of absorbance against time for the oxidation of 
aa, and {3{3 cross-linked hemoglobin respectively. For the oxidation process the potential 
was stepped from -0.509V to 0.489V, and -0.609V to 0.589V for aa, and {3{3 cross-
linked hemoglobin respectively. The average oxidation time after reduction of the met 
forms is 1000 seconds for hemoglobin, aa, and {3{3 cross-linked hemoglobin. But, 
starting with oxy forms and oxidizing to the met forms, it only takes 300 seconds on the 
average. The reason for this is unknown. Full oxidation is considerably delayed for the 
oxidation of the reduced met forms of hemoglobin and its cross-linked products. This 
behavior of delayed oxidation of the reduced met forms was also observed by Daniela 
Schlereth et al. 19 This behavior was attributed to possible different redox states of 
hemoglobin molecule depending upon the number of heme groups oxidized in the same 
molecule. 19 This behavior could also reflect the existence of single/multilayer of 
adsorbed protein molecules onto the electrode surface, making the electrode a chemically 
modified electrode and acting as an "electron shuttle" to provide redox coupling between 
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Figure 23. Plot of absorbance against time for the oxidation of 5. 35 micromolar aa 
hemoglobin in pH 7.0, 0.10M phosphate+ 0.10M KCl buffer system from -0.509V to 
















Figure 24. Plot of absorbance against time for the oxidation of 5.35 micromolar /3/3 
hemoglobin in pH 7.0, 0.10M phosphate + 0.10M KCl buffer system from -0.609V to 
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the electrode and the heme in the protein. Scheller et al proposed the formation of a 
multilayer of adsorbed protein which acts in transferring electrons from the electrode to 
freely diffusible protein as the mechanism for the electron transfer of myoglobin and 
hemoglobin at bare mercury electrodes. 11 
Figure 25 shows the cyclic voltabsorptometry plot for the reduction of 5.35 
micromolar {3(3 hemoglobin in pH 7.0, 0.10M phosphate + 0.10M KCl buffer system 
from 0.489V to -0.500V at scan rate of 1 mV/s monitored at 406nm wavelength. During 
the reductive process, the absorbance values were relatively constant between potentials 
of 0.469V to 0.050V. This corresponds to a period where no electrode reaction occurs. 
As the potential is scanned more negative of 0.050V, gradual and steady decrease of 
absorbance occurs as the protein is progressively reduced. The drop in absorbance began 
in ernest at about -0.125V. The reduction process is essentially complete at -0.335V. 
Figure 26 shows the cyclic voltabsorptometry plot for the oxidation of 5. 35 
micromolar {3(3 hemoglobin in pH 7.0 0.lM phoshate + 0.lM KCl buffer system from 
-0.509V to 0.489V at scan rate of 1 mV/s monitored at 406nm wavelength. The 
oxidative process shows a different pattern from the reductive process. Different stages 
can be observed. But the stage are not well defined. These stages have been attributed 
to three different electrochemical processes in the literature. 19 The rise in absorbance 
began at about -0.392V. The true E0 value of the system must be bracketed by the value 
which could be estimated from Figs. 25 and 26, that is, the potential should be between -
0.392V to-0.125V. The lack of agreement between the reduction and oxidation scan is 
consistent with the results in Figs. 22 and 24 which show that the time scale for 
72 
Figure 25. Cyclic voltabsorptometry plot for the reduction of 5.35 micromolar {3{3 
hemoglobin in pH 7.0, 0.lOM phosphate + 0.lOM KCl buffer system from 0.489V to 
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Figure 26. Cyclic voltabsorptometry plot for the oxidation of 5.35 micromolar {3(3 
hemoglobin in pH 7.0, 0.lM phosphate + 0.lM KCl buffer system from -0.509V to 
0.489V at scan rate of 1 mV/s monitored at 406nm wavelength. 
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reduction is 130s while the time scale for oxidation is 1000s. In summary, the electron 
transfer process at the electrode surface is slow enough that complete equilibrium is not 
obtained even at a sweep rate of lmV/s. 
Similar results were observed for aa hemoglobin, and uncrosslinked hemoglobin. 
The full utility of the thin layer spectroelectrochemistry cell is shown when the potential 
is changed gradually in steps. 
Figure 27 shows the absorbance spectrum of 2.017 micromolar aa hemoglobin 
in pH 7. 0 0. lOM phosphate + 0. lOM KCl buffer system at several applied potentials. 
The figure shows the absorption spectra associated with small, incremental potential steps 
applied to aa crosslinked hemoglobin. The plot shows a gradual decrease in absorbance 
peak from -0.113V to -0.413V as the aa hemoglobin is reduced. The absorbance peak 
became relatively constant after -0.413V indicating that the reduction is essentially 
complete after this potential. 
Figure 28 shows the plot of absorbance against potential at 406nm wavelength for 
oxyhemoglobin. As the potential is scanned positive of -0.20V, the absorbance value 
increases gradually as the hemoglobin is being oxidized from Fe2+ to Fe3 +. The 
absorbance values became relatively constant after 0.300V indicating almost complete 
oxidation of the hemoglobin. 
Figure 29 shows the Nemstian plot obtained for 13.81 micromolar hemoglobin 
in pH 7.0, 0.10M phosphate + 0. lOM KCl buffer system at 408nm wavelength. In this 
plot a straight line was obtained with the slope of 0 .18. The slope gives a n value of 
0.33. The theoritical value is 0.01475 for n value of 4. The n value obtained might 
77 
Figure 27. Absorbance spectrum of 2.017 micromolar aa hemoglobin in pH 7. 0, 0 .1 OM 
phosphate + 0.10M KCl buffer system at several applied potential: 
(a) -0.113V, (b) -0.211V, (c) -0.263V, (d) -0.363V, (e) -0.413V. 








Figure 28. Plot of absorbance against potential for 13.81 micromolar hemoglobin in 








Fgure 29. Nerstian plot obtained for 13.81 micromolar hemoglobin in pH 7.0, 0.10M 



















suggest that true Nemstian conditions have not been fully obtained. It is interesting to 
note though, that the n value obtained in the literature is between 1 and 2.47· 48 · The 
intercept ( E0 ' ) was found to be -0.023V Vs SCE which compares favorably with the 
literature value of -0. 070V. 45 
Figure 30 shows the plot of absorbance against potential for 13.81 micromolar 
aa hemoglobin in pH 7 .0, 0.10M phosphate + 0.10M KCl buffer system at 408nm 
wavelength. As the potential is scanned positive of -0.363V, the absorbance value 
increases gradually as the cm hemoglobin is being oxidized from Fe2+ to FeH. The 
absorbance values became relatively constant after 0.15V indicating almost complete 
oxidation of the aa hemoglobin. 
Figure 31 shows the Nemstian plot obtained for 13.81 micromolar aa 
hemoglobin in pH 7. 0, 0. lOM phosphate + 0. lOM KCl buffer system at 408nm 
wavelength. Again, a good linear fit was obtained ( r2 = 0.9569). However, the slope 
is like that of hemoglobin, close to 0.20V. The intercept yeilds an estimate of E0 = 
-0.237V Vs SCE. 
From the Nemstian plot of Eapp1. Vs the log of [ox]/ [red], the E0 ' value can be 
obtained from the intercept on the y-axis and the slope gives the number of electrons 
transferred. The formal potential of hemoglobin, and aa hemoglobin were determined 
using the Nernstian plot (Table 1 and 2). The formal potential of {3{3 hemoglobin was 
estimated from the cyclic voltabsorptometry plot at scan rate lmV/s (Fig. 25), which 
gave a value of -0.201 V. Crosslinking affects both the time for electrolysis and the redox 
value measured. Crosslinking enhance the rate of electrolysis of {3{3 crosslinked 
84 
Figure 30. Plot of absorbance against potential for 13. 81 micromolar aa hemoglobin 
in pH 7.0, 0.10M phosphate + 0.10M KCl buffer system at 408nm wavelength. 
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Figure 31. Nernstian plot obtained for 13.81 micromolar aa hemoglobin in pH 7.0, 
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Table 1: Oxy and Met Hemoglobin Experiments 
Date 
double step single step multiple Comments 
step 
613194 no A change 





6/10194 A decrease not 
increase 
6/16194 Fluctauting A 
6122194 Fluctuating A 
6129194 A Fluctuating A 
6129194 B Success!! 
6130194 Success!! 
2/13195 (red) instrm. error 
2/15195 (ox) fluctuating A 
Met-Hb 
2/15195 B (ox) fluctuating A 
2/15/95 (red) Success!! 
2/15195 (ox) Success!! 
2115195 (ox) Success!! 
2118195 (?) ? 
Data 
E, slope, R2 or rate 
4.17xl0-6 Auls 
-0. 022 V, 0. 1801 , 0. 964 













Table 2: Crossli11kcd I lcmoglohin Experiments. 
Date 
Single step Multiple step Comments 
7/16/94 Success 
7/27/94 Success 
2/1 (,/95 (ox) Success 
2/23/95(rc<l) Success 
2/23/95(ox) Success 
2/16/95(ox) Fluctuating Abs. 
7/16/94 Fluctuating Abs. 
7 /I 6/94(nxl) Fluctuating Abs. 
8/1/95 Abs. decrease not 
increase 
2/5/95(rcd) Fluctuating Abs. 
2/l l/95(rcd) 
2/l l/95(ox) Decrease not 
increase 




E0 ', Slope, R2 or R 
-0.2129, 0.1998, 0.9561 
-0.133, 0.1197, 0.6807 
6.9616 X 10·1 Auls 
5.7724 X 10·4 Auls 
7. 9724 X I 0·1 Auls 
1.164 X 10·4 Auls 
6.759 X 10·1 Auls 
3.870 X 10·4 Auls 
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hemoglobin substantially. 
Table 1 shows the various attempts made at obtaining the E0 ' values for 
hemoglobin and also to find out how long it takes to oxidized and reduce hemoglobin at 
an unmodified electrode. 
Table 2 shows the values obtained for the cross-linked hemoglobin products. It 
generally takes a shorter time to run {3{3 crosslinked hemoglobin experiments. 
Hemoglobin experiments are very difficult to run because any slight change in 
experimental conditions might lead to fluctuating absorbance values or the absorbance 
values might go in the opposite direction. 
The shift to a negative potential implies that the crosslinked forms of 
oxyhemoglobin preferentially stabilize the trivalent iron (met heme). 
Figures 32 and 33, show the deoxycrystal structures of aa and {3{3 crosslinked 
hemoglobin respectively. The X-ray crystallographic studies of aa and {3{3 crosslinked 
hemoglobin suggest some movements of the amino acid residues within the central cavity 
of the tetramer. 46 This movement might be responsible for the preference of the heme 
in the + 3 oxidation state as compared to the native hemoglobin, thus stabilizing it. The 
protein moiety influences both the redox potential and the electrochemical behavior of 
the prosthetic groups inside a protein. The following are the characteristic features of 
electrode reaction of hemoglobin and other proteins (myoglobin, etc) that has been noted 
by myself and other reseachers45 : 
1. Hemoglobin and its cross-linked products are strongly adsorbed at the 
electrode-electrolyte solution interface. 45 
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Figure 32. Molecular modelling structure for aa hemoglobin (Adapted from Fernandez 
d 1 ssertation with permissiom46). 
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Figure 33. Molecular modelling structure for {3(3 hemoglobin (Adapted from Fernandez 
dissertation with permissiom46). 
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2. Adsorption at an electrode surface may lead to conformational changes or to 
a complete denaturation of the adsorbed protein, as found at other interfaces.45 . 
3. The protein/hemoglobin concentration at the electrode is increased m 
comparison with the bulk solution, when protein or hemoglobin is adsorbed at the 
electrode surface. 45 
4. Diffusion of the macromolecule is slow, therefore only very small or no 
Faradaic currents may be measured. 45 
5. The reducible or prosthetic groups of the protein constitute only a very small 
part of the molecular surface; thus the interaction with the electrode is sterically 
hindered. In most cases, electroactive groups are "buried" by the isolating protein 
fabric. 45 
The following additional observations concerning the 
spectroelectrochemicalexperiments of hemoglobin and its cross-linked products has been 
made by myself: 
1. It is extremely important to have a reproduceable electrode surface to obtain 
consistent results . 
2. The sensitivity of the spectrophotometer is also crucial since absorbance values 
of the protein is very small. 
3. Reproducible experimental conditions such as cell volume, optical light path, 
and a clean spectroelectrochemical cell surface ( especially the outside surface) are very 
important. 
4. Crosslinking of the hemoglobin affects the time scale of the electrochemical 
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reduction and oxidation. 
5. Crosslinking of the hemoglobin results in a conformation which favors Fe (III) 
oxidation state. 
CHAPTER 4 
SUMMARY AND FUTURE DIRECTION 
In this project, the design and construction of optically transparent thin-layer cell 
has been described. Electrochemical and thin-layer spectroelectrochemical behavior of 
the cell were confirmed by using ferri/ferrocyanide as the test system. 
Using the spectroelectrochemical system, hemoglobin, lysine (99)ai-lysine (99)a2 
cross-linked hemoglobin, and lysine (82)/3i-lysine (82)/32 cross-linked hemoglobin, were 
reduced and oxidized at an unmodified platinum gauze electrode with the reduction rate 
being faster than the oxidation rate. The system was also used to determine the E0 ' values 
for hemoglobin and its cross-linked products. The E0 ' values of aa, and /3/3 cross-linked 
hemoglobin are more negative than uncrosslinked hemoglobin indicating preference of 
the crosslinked products for the + 3 oxidation state. The conformation/configuration of 
hemoglobin and its crosslinked products at the electrode surface play a role in their 
electrochemical behavior. 
Spectroelectrochemical studies only employs a small amount of solution for 
obtaining electrochemical parameters and properties of redox processes. This will benefit 
electrochemical research in which small samples are available, such as crown ether 
complexes and anticancer pharmaceuticals. 
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In the future, there is a need to construct a system that is completely anaerobic. 
Deoxyhemoglobin could be studied with the anaerobic system. The spectroscopy and 
electrochemistry need to be controlled through interfaces from data acquition and 
treatment software. None is available in the market at present. The software program 
should be capable of runing different types of spectroelectrochemical experiments such 
as double step voltabsorptometry, cyclic voltabsorptometry, and potential step 
voltabsorptometry experiments. 
APPENDIX 1 
WORK NOT PRESENTED IN THESIS 
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Other projects that I worked on during the course of my time at Loyola University 
included the electrochemical behavior of myoglobin. The research conducted on this 
protein laid the groundwork for subsequent work done on hemoglobin. 
Myoglobin, the small heme protein (molecular weight 17800) found primarily in 
cardiac and red skeletal muscles, functions physiologically in its reduced state to store 
dioxygen and facilitate its transport to the mitochondria. Myoglobin has been used in the 
literature as a model compound to study the dioxygen-binding properties of the larger , 
more complex hemoglobin. 48 Literature shows that myoglobin and hemoglobin have 
similar electrochemical behavior. 49 
Preliminary studies show that small current signal was observed for myoglobin 
with the cathodic peak current being larger than anodic peak current. But the signal 
obtained is nearly a reversibly cyclic voltammogram. The addition of a mediator 
compound (methylene blue), which on its own shows a well developed asymmetric peak 
with a slightly sharper anodic peak current, did not increase the signal, but sharpens the 
anodic peak of the methylene blue drastically. The following results were also obtained: 
( 1) The most ideal scan rate for running the CV is between 16 and 25 m V / s. 
(2) Myoglobin shows best reversibility at 16 and 20 mV/s, Ipc/ Ipa which is a 
measure of reversibility is equal to 1. 
(3) The cathodic peak current for myoglobin in methylene blue is less than or 
equal to the sum of individual cathodic peak currents. 
(4) The anodic peak current for myoglobin in methylene blue is enhanced, the 
observed peak current is far greater than individual peak currents. 
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(5) Peak current increases with increase in pH for myoglobin in methylene 
blue, and methylene blue. In the case of myoglobin, it increases up to pH 
5.85 but lowest current was observed at pH 6.24. 
Experimental works with chemically modified electrodes did not yield any new results 
from the ones obtained for mediator compounds added to the solution containing 
myoglobin. But new problems were observed such as desorption of the mediator 
compounds from the surface of the electrode. The current signals, both cathodic and 
anodic, are generally smaller than those obtained for the mediator compound in solution 
with the myoglobin. 
Different electrodes, such as glass doped indium tin oxide electrode, platinum 
wire electrode, glassy carbon electrode, were used to study electrochemical behavior of 
myoglobin. The best result was obtained using glassy carbon electrode. All the 
observations mentioned above were obtained using glassy carbon electrode and saturated 
calomel electrode as the reference. 
REFERENCES 
1. Dickerson R. E.; Geis, I. Hemoglobin: Structure, Function, Evolution and 
Pathology. The Benjamin/Cummings Publishing Co. Inc. California, 1983 pg. 20-
21. 
2. White, A.; Handler, P.; Smith, E. L.; Hill, R. L.; Lehman, I. R. Principle of 
Biochemistry, McGraw-Hill, New York, 1978. 
3. Lehman, H.; Huntsman, R. G. Man's Haemoglobin, North-Holland Publishing 
Company, Amsterdam. 1974. 
4. Wang, E.; Zhou, J. Electrochimicia Acta, 37 1992 595-602. 
5. Winslow, R. M.; Hemoglobin-based Red Cell Substitutes. The Johns Hopkins 
University Press Baltimore and London 1992 pg. 42-45, 73-75. 
6. Stryer, L.; Biochemistry, W. H. Freeman and Company New York 1988 pg. 
144. 
7. Walder, J. A.; Walder, R. Y.; Arnone, A.; J. of Biological Chemistry 2611986 
9929-9937. 
8. Walder, J. A.; Walder R., and Arnone, A. J. mo/ Biol, 141, 1980, 195 - 216 
9. Chatterjee, R.; Walder, R. Y.; Arnone, A.; Walder, J. J. A.; Biochemistry 21, 
1982, 5901 - 5909 
10. Jiagi, D.; Xingliang, W.; Xiaohong, Z.; Ging, W.; Zifeng, D. Fenxi Hauxue, 
19 (8), 1991, 949 - 951. 
11. Scheller, F.; Janchen, M.; Etzold, G.; Will, H. Bioelectrochem. Bioenergy., 
4, 1977, 512. 
12. Scheller, F.; Bioelectrochem. Bioenerg., 4, 1977, 490-492. 
102 
103 
13. Kuznetsov, B. A.; Shumakovic, G. P.; Mestechkina, N. M. Bioelectrochem. 
Bioenerg., 4, 1977, 512-515. 
14. Kwee, S. Bioelectrochem. Bioenerg., 16, 1986, 99-101. 
15. Song, S. Dong, S. Bioelectrochem. Bioenerg., 19, 1988, 337-339. 
16. Stargardt, J. F.; Hawkridge, F. M.; Landrum, H. L. Anal. Chem. 50, 1978, 
930 - 932-933. 
17. Cotton, T. M. Schultz, S. G. Van Duyne, R. P. J. Am. Chem. Soc., 102, 1980, 
7960-7962. 
18. Ye, J.; Baldwin, R. P. Anal. Chem. 60 1988 2263-2268. 
19. Schlereth, D.; Mantele, W. Biochemistry, 31 1992 7494-7502. 
20. Zhou, J. X.; Wang, E. K. Chinese Chemical Letters, 2 1991 239-242. 
21. Wang, E.; Zhou, J. Electroanalysis, 3 1991 203-207 
22. Zhu, Y.; Dong, S. Bioelectrochemistry and Bioenergetics, 24 1990 23-31. 
23. Dong, S.; Zhu, Y.; Song, S. Bioelectrochemistry and bioenergetics, 21 1989 
233-243. 
24. Zhu, Y.; Dong, S. Bioelectrochemistry and Bioenergetic, 26 1991 351-357. 
25. King, B. C.; Hawkridge, F. M. J. Am. Chem. Soc. 1149 1992 10603-0608 
26. Ohno, H.; Yamaguchi, N.; Watanabe, M. Polymers for Advanced 
Technologies 4 1992 133-138. 
27. Ohno, H.; Tsukuda, T. Polym. Prep., Japan 41, 1992, 1041-1043. 
28. Ohno, H.; Tsukuda, T. J. Electroanalchem., 341, 1992, 137-139. 
29. Yamaguchi, N.; Suzuki, T.; Ohno, H. Polym. Prep. Japan, 40, 1991, 598-600. 
30. Ohno, H. Electrochem. Acta, 37, 1992, 1649-1653. 
31. Evans, D. H.; O'Conell, K. M. et. al., J. of Chem. Educ. 60 1983 290-292. 
104 
32. Fitch, A. Electrochemistry for the Phobia Chapter 1 pg. 6 in Press. 
33. Zhangyu, Y.; Tiande, G.; Mei, Q. Anal. Chem. 1994, 66, 497-502. 
34. Hawkridge, F. M.; Taniguchi, I. J. Electroanal. Chem. 333 1992 331-338. 
35. Rubinson, K. A.; Mark Jr., H. B. Anal. Chem. 54, 1982, 1204 -1206. 
36. Lin, X. Q.; Kadish, K. M. Anal. Chem. 57 1985 1498-1501. 
37. Scherson, D. A.; Sarangapani, S.; Urbach, F. L. Anal. Chem. 57, 1985, 1501 -
1503. 
38. Gui, Y.; Soper, S. A.; Kuwana, T. Anal. Chem. 60, 1988, 1645 - 1648. 
39. Zak, J.; Porter, M. D.; Kuwana, T. Anal. Chem. 55, 1983 2219 - 2222. 
40. Bard, A. J.; Faulkner, L. R. Electrochemical Methods: Fundamentals and 
Application; New York, 1980; pg. 409-413. 
41. Kissinger, P. T.; Heineman, W. R. J. Chem. Educ. 60 1983 702-705 
42. Heineman, W. R. J. of Chem. Educ. 60 1983 305-307. 
43. Heinman, W. R.; Norris, B. J.; Goelz, J. F. Anal. Chem. 47, 1975, 79-83. 
44. DeAngelis, T. P.; Heinman, W. R. J. Chem. Educ. 53, 1976, 594-596. 
45. Dryhurst, G.; Kadish, K. M.; Scheller, F.; Renneberg, R. Biological 
Electrochemistry, Vol 1, Academic Press, 1982. 
46. Fernandez, E. J.; X-ray Crystallography Studies of hemoglobin and cross-linked 
hemoglobin. Ph.D. thesis Jan. 1995. 
VITA 
The author, Ayoola 0. Alabi, was born in Lagos Island, Nigeria. 
In October, 1984, he entered University of Lagos and received a Bachelor of Science 
degree in Chemistry in July, 1987. Upon graduation, he joined The Federal Institute of 
Industrial Research, Oshodi, Lagos, as a research assistant. 
In August, 1992, Mr. Alabi joined the Department of Chemistry at Loyola University 
Chicago in order to pursue graduate studies in analytical chemistry. He was awarded graduate 
assistantship from January 1993 to July 1994. He was funded by Dr. Alanah Fitch during the 
write up of the thesis. 
In August 1994, Mr. Alabi started his medical education at the University of Illinois 
College of Medicine, Urbana-Champaign. 
105 
APPROVAL SHEET 
The thesis submitted by Ayoola 0. Alabi has been read and approved by the followinng 
connnittee: 
Dr. Alanah Fitch, Director 
Professor, Chemistry 
Loyola University Chicago 
Dr. Kenneth Olsen 
Professor, Chemistry 
Loyola University Chicago 
Dr. David Crumrine 
Associate Professor, Chemistry 
Loyola University Chicago 
The final copies have been examined by the director of the thesis and the signature which 
appears below verifies the fact that any necessary changes have been incorporated and 
that the thesis is now given final approval by the Connnittee with reference to content and 
form. 
The thesis is therefore accepted in partial fulfilhnent of the requirements for the degree 
of Master of Science. 
"-(It o/'7' I ' .i 
Date 
l ( 
.-L~ . 
Director's Signature 
